This chart displays the top 10 holdings in Regeneron Pharmaceuticals, Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 2 positions.

The assets under management (AUM) of Regeneron Pharmaceuticals, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 47.884M in assets, with a quarterly growth rate of 41.68% and a 2-quarter average growth rate of -26.75%. The portfolio is managed by Leonard Brooks, and others.